NORDIC BIOTECH K/S: Financial statements 2012
CVR: 26290724
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
NORDIC BIOTECH K/S (CVR 26290724) has filed annual accounts for 2012. In 2012, the company reported a net result of DKK 571,212,498. Equity in the 2012 report amounted to DKK 723,802,190. The solvency ratio was 100%.
- Profit/Loss
- DKK 571,212,498
- Equity
- DKK 723,802,190
- Total Assets
- DKK 724,031,923
Official annual report
Keep an eye on NORDIC BIOTECH K/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of July 5, 2012, JUT NR. 2180 A/S has been appointed auditor of NORDIC BIOTECH K/S.
As of July 5, 2012, EY Danmark A/S has stepped down as auditor of NORDIC BIOTECH K/S.
About NORDIC BIOTECH K/S
NORDIC BIOTECH K/S was a Danish company of the type Kommanditselskab based in Hellerup, founded in 2001. The company has been dissolved on 22 December 2025. The company was registered under the industry Anden finansiel formidling i.a.n.. The company has 0 employees (2011). In 2024, the company reported a gross profit of DKK -157,000 and a net result of DKK 101,458,000 compared with DKK 1,254,000 the year before. Equity in the 2024 report amounted to DKK 127,032,000.